drugset / Trial / NCT01010932

Carotid and Vertebral Magnetic Resonance Angiography (MRA) Study Comparing Dotarem and Time Of Flight (TOF)

NCT01010932

Phase 3 Completed 222 enrolled Guerbet
NaSingle-groupOpen-labelDiagnostic

Summary

The study will evaluate the efficacy and safety of Dotarem enhanced MRA in patients suffering from carotid or vertebral arterial disease.

Timeline

Start
2009-10
Primary completion
2010-12
Completion
2010-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Gadoterate meglumine Diagnostic / imaging agent 0.2 unknown